Unknown

Dataset Information

0

Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.


ABSTRACT: Estrogen deficiency in menopause is a major cause of osteoporosis in women. Estrogen acts to maintain the appropriate ratio between bone-forming osteoblasts and bone-resorbing osteoclasts in part through the induction of osteoclast apoptosis. Recent studies have suggested a role for Fas ligand (FasL) in estrogen-induced osteoclast apoptosis by an autocrine mechanism involving osteoclasts alone. In contrast, we describe a paracrine mechanism in which estrogen affects osteoclast survival through the upregulation of FasL in osteoblasts (and not osteoclasts) leading to the apoptosis of pre-osteoclasts. We have characterized a cell-type-specific hormone-inducible enhancer located 86 kb downstream of the FasL gene as the target of estrogen receptor-alpha induction of FasL expression in osteoblasts. In addition, tamoxifen and raloxifene, two selective estrogen receptor modulators that have protective effects in bone, induce apoptosis in pre-osteoclasts by the same osteoblast-dependent mechanism. These results demonstrate that estrogen protects bone by inducing a paracrine signal originating in osteoblasts leading to the death of pre-osteoclasts and offer an important new target for the prevention and treatment of osteoporosis.

SUBMITTER: Krum SA 

PROVIDER: S-EPMC2241656 | biostudies-literature | 2008 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival.

Krum Susan A SA   Miranda-Carboni Gustavo A GA   Hauschka Peter V PV   Carroll Jason S JS   Lane Timothy F TF   Freedman Leonard P LP   Brown Myles M  

The EMBO journal 20080124 3


Estrogen deficiency in menopause is a major cause of osteoporosis in women. Estrogen acts to maintain the appropriate ratio between bone-forming osteoblasts and bone-resorbing osteoclasts in part through the induction of osteoclast apoptosis. Recent studies have suggested a role for Fas ligand (FasL) in estrogen-induced osteoclast apoptosis by an autocrine mechanism involving osteoclasts alone. In contrast, we describe a paracrine mechanism in which estrogen affects osteoclast survival through t  ...[more]

Similar Datasets

| S-EPMC4563780 | biostudies-literature
| S-EPMC4646684 | biostudies-literature
| S-EPMC6237570 | biostudies-literature
| S-EPMC3488055 | biostudies-literature
| S-EPMC3495082 | biostudies-literature
| S-EPMC5171795 | biostudies-literature
2007-06-01 | GSE7798 | GEO
| S-EPMC5112117 | biostudies-literature
| S-EPMC6158087 | biostudies-literature
| S-EPMC3421196 | biostudies-literature